The Procter & Gamble Company Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-07-11: Reporting owner Jejurikar Shailesh; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-07-11: Reporting owner Whaley Susan Street; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-07-11: Reporting owner Raman Sundar G.; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-07-11: Reporting owner Purushothaman Balaji; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-07-11 | Jejurikar Shailesh Officer (Chief Operating Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +59 944 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Whaley Susan Street Officer (Chief Legal Officer & Secy) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 1,428 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Raman Sundar G. Officer (CEO-Fabric & Home Care) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 1,957 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 2,673 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Pritchard Marc S. Officer (Chief Brand Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 12,408 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 6,024 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Keith R. Alexandra Officer (CEO - Beauty) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 2,054 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 1,678 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Schulten Andre Officer (Chief Financial Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 1,526 owned after | $0.00 | $148.08 | 2023-08-07 |
| 2023-07-11 | Davis Jennifer L. Officer (CEO - Health Care) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 4,247 owned after | $0.00 | $148.08 | 2023-08-04 |
| 2023-07-11 | Moeller Jon R Director, Officer (Chairman, President and CEO) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 7,481 owned after | $0.00 | $148.08 | 2023-08-03 |
| 2023-07-11 | Janzaruk Matthew W. Officer (SVP - Chief Accounting Officer) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100 1,829 owned after | $0.00 | $148.08 | 2023-08-02 |
| 2023-07-11 | Francisco Ma. Fatima Officer (CEO - Baby, Fem & Family Care) | 4 | Series A Preferred Stock Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +109 3,478 owned after | $0.00 | $148.08 | 2023-08-01 |
| 2023-01-04 holding as of filing | Purushothaman Balaji Officer (Chief Human Resources Officer) | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2023-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |